{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-23-000005","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2023-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.040237+00:00","generated_at":"2026-06-13T03:03:53.285276+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Teladoc Health Q2 revenue $652M (+10% YoY); adj EBITDA $72.2M beats outlook","bullets":["Revenue $652.4M (+10% YoY); Integrated Care $360.1M (+5%), BetterHelp $292.4M (+18%).","Net loss $65.2M ($0.40/share) vs $3.1B loss in Q2 2022 which included $3.03B goodwill impairment.","Adjusted EBITDA $72.2M (+54% YoY), exceeding expectations; operating cash flow $101.2M.","Q3 2023 guidance: revenue $650-$675M, adj EBITDA $72-$82M; full-year adj EBITDA $300-$325M.","U.S. Integrated Care members guided at ~86 million for Q3 and full year 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-23-000005","json":"https://secwatch.observer/filing/0001477449-23-000005.json","markdown":"https://secwatch.observer/filing/0001477449-23-000005.md","text":"https://secwatch.observer/filing/0001477449-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000005/0001477449-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000005/tdoc-20230725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T03:03:53.285276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e9cd592734c279ecfdeaaad59ebf74275bac2c58","claim":"Teladoc Health, Inc. reported Six Months Ended June 30, 2023 results: revenue $1,281.7 million, net income $134.4 million loss, EPS $0.82 loss per share.","evidence_excerpt":"quarter 2022. Adjusted gross margin (1) was 70.8% for second quarter 2023, compared to 69.2% for second quarter 2022. Six Months Ended June 30, 2023 Revenue increased 11% to $1,281.7 million from $1,157.7 million in the first half of 2022. Access fees revenue grew 12% to $1,126.5 million, and other revenue grew 5% to $155.1 million. U.S. revenue grew 9% to $1,103.4","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000005/0001477449-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Six Months Ended June 30, 2023"},{"label":"Revenue","value":"$1,281.7 million"},{"label":"Net income","value":"$134.4 million loss"},{"label":"EPS","value":"$0.82 loss per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ee87ba78e191c9772d66bfae53cc44232ff72663","claim":"Teladoc Health, Inc. reported Year ending December 31, 2023 results: revenue $2,600 - $2,675 million, EPS ($1.60) - ($1.25) loss per share. Guidance initiated.","evidence_excerpt":"For the year ending December 31, 2023, we expect: Full Year 2023 Outlook Range Revenue $2,600 - $2,675 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000005/0001477449-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Year ending December 31, 2023"},{"label":"Revenue","value":"$2,600 - $2,675 million"},{"label":"EPS","value":"($1.60) - ($1.25) loss per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"ffe9941c7466c87b914514e303feb16c7dc174a6","claim":"Teladoc Health, Inc. reported Third quarter 2023 results: revenue $650 - $675 million, EPS ($0.50) - ($0.40) loss per share. Guidance initiated.","evidence_excerpt":"For third quarter 2023, we expect: 3Q 2023 Outlook Range Revenue $650 - $675 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000005/0001477449-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Third quarter 2023"},{"label":"Revenue","value":"$650 - $675 million"},{"label":"EPS","value":"($0.50) - ($0.40) loss per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}